ARKG vs IVE
ARK Genomic Revolution ETF vs iShares S&P 500 Value ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
IVE—
iShares S&P 500 Value ETF
S&P 500 value subset.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | IVE |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
IVE top holdings
Holdings data unavailable for IVE.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About IVE
IVE (iShares S&P 500 Value ETF) is S&P 500 value subset.